Pharmacies - Germany

Germany

The Pharmacies market in Germany is expected to achieve a revenue of €72.97bn by 2024.
It is projected to display an annual growth rate (CAGR 2024-2029) of 3.64%, leading to a market volume of €87.24bn by 2029.
When compared globally, United States is anticipated to generate the highest revenue, amounting to €355.40bn in 2024.
In terms of per capita revenue, in Germany is estimated to generate €0.88k in 2024.
Germany's pharmacies are increasingly shifting towards offering holistic health services, including natural remedies and alternative therapies.

Key regions: United States, China, Germany, Japan, Europe

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Pharmacies market in Germany has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Pharmacies market in Germany have shifted towards a greater emphasis on health and wellness. Consumers are becoming more conscious of their overall well-being and are seeking out products and services that promote a healthy lifestyle. This has led to an increased demand for natural and organic products, as well as a growing interest in alternative medicine and holistic approaches to healthcare. Trends in the market have also played a role in the growth of the Pharmacies market in Germany. One notable trend is the increasing use of e-commerce and online platforms for purchasing healthcare products. With the convenience of online shopping and the ability to compare prices and read reviews, many consumers are opting to purchase their medications and health products online. This trend has been further accelerated by the COVID-19 pandemic, as people have been encouraged to stay home and limit their exposure to public spaces. Another trend in the market is the focus on personalized healthcare. Consumers are seeking out pharmacies that offer personalized services and tailored advice. This includes services such as medication reviews, health consultations, and customized treatment plans. Pharmacies that can provide these personalized services are more likely to attract and retain customers in the competitive market. Local special circumstances in Germany have also contributed to the growth of the Pharmacies market. Germany has a well-established healthcare system that places a strong emphasis on preventive care and patient education. This has created a culture of health-consciousness among the population, leading to increased demand for healthcare products and services. Underlying macroeconomic factors have also played a role in the growth of the Pharmacies market in Germany. The country has a stable economy and a high standard of living, which allows consumers to prioritize their health and wellness. Additionally, the aging population in Germany has increased the demand for healthcare products and services, including medications and over-the-counter remedies. In conclusion, the Pharmacies market in Germany has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards health and wellness, the use of e-commerce, the focus on personalized healthcare, and the country's healthcare system and economic stability have all contributed to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.